SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Olafsson S.)
 

Search: WFRF:(Olafsson S.) > DNA methylation as ...

DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis

Kular, L (author)
Karolinska Institutet
Liu, Y (author)
Ruhrmann, S (author)
show more...
Zheleznyakova, G (author)
Karolinska Institutet
Marabita, F (author)
Karolinska Institutet
Gomez-Cabrero, D (author)
Karolinska Institutet
James, T (author)
Karolinska Institutet
Ewing, E (author)
Karolinska Institutet
Linden, M (author)
Gornikiewicz, B (author)
Aeinehband, S (author)
Stridh, P (author)
Karolinska Institutet
Link, J (author)
Andlauer, TFM (author)
Gasperi, C (author)
Wiendl, H (author)
Zipp, F (author)
Gold, R (author)
Tackenberg, B (author)
Weber, F (author)
Hemmer, B (author)
Strauch, K (author)
Heilmann-Heimbach, S (author)
Rawal, R (author)
Schminke, U (author)
Schmidt, CO (author)
Kacprowski, T (author)
Franke, A (author)
Laudes, M (author)
Dilthey, AT (author)
Celius, EG (author)
Sondergaard, HB (author)
Tegner, J (author)
Karolinska Institutet
Harbo, HF (author)
Oturai, AB (author)
Olafsson, S (author)
Eggertsson, HP (author)
Halldorsson, BV (author)
Hjaltason, H (author)
Olafsson, E (author)
Jonsdottir, I (author)
Stefansson, K (author)
Olsson, T (author)
Karolinska Institutet
Piehl, F (author)
Karolinska Institutet
Ekstrom, TJ (author)
Karolinska Institutet
Kockum, I (author)
Karolinska Institutet
Feinberg, AP (author)
Jagodic, M (author)
Karolinska Institutet
show less...
 (creator_code:org_t)
2018-06-19
2018
English.
In: Nature communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 9:1, s. 2397-
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The human leukocyte antigen (HLA) haplotype DRB1*15:01 is the major risk factor for multiple sclerosis (MS). Here, we find that DRB1*15:01 is hypomethylated and predominantly expressed in monocytes among carriers of DRB1*15:01. A differentially methylated region (DMR) encompassing HLA-DRB1 exon 2 is particularly affected and displays methylation-sensitive regulatory properties in vitro. Causal inference and Mendelian randomization provide evidence that HLA variants mediate risk for MS via changes in the HLA-DRB1 DMR that modify HLA-DRB1 expression. Meta-analysis of 14,259 cases and 171,347 controls confirms that these variants confer risk from DRB1*15:01 and also identifies a protective variant (rs9267649, p < 3.32 × 10−8, odds ratio = 0.86) after conditioning for all MS-associated variants in the region. rs9267649 is associated with increased DNA methylation at the HLA-DRB1 DMR and reduced expression of HLA-DRB1, suggesting a modulation of the DRB1*15:01 effect. Our integrative approach provides insights into the molecular mechanisms of MS susceptibility and suggests putative therapeutic strategies targeting a methylation-mediated regulation of the major risk gene.

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view